1. Home
  2. HUMA vs MQT Comparison

HUMA vs MQT Comparison

Compare HUMA & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • MQT
  • Stock Information
  • Founded
  • HUMA 2004
  • MQT 1992
  • Country
  • HUMA United States
  • MQT United States
  • Employees
  • HUMA N/A
  • MQT N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • MQT Investment Bankers/Brokers/Service
  • Sector
  • HUMA Health Care
  • MQT Finance
  • Exchange
  • HUMA Nasdaq
  • MQT Nasdaq
  • Market Cap
  • HUMA 250.2M
  • MQT 207.5M
  • IPO Year
  • HUMA N/A
  • MQT N/A
  • Fundamental
  • Price
  • HUMA $1.51
  • MQT $9.57
  • Analyst Decision
  • HUMA Strong Buy
  • MQT
  • Analyst Count
  • HUMA 8
  • MQT 0
  • Target Price
  • HUMA $10.88
  • MQT N/A
  • AVG Volume (30 Days)
  • HUMA 5.9M
  • MQT 52.5K
  • Earning Date
  • HUMA 08-11-2025
  • MQT 01-01-0001
  • Dividend Yield
  • HUMA N/A
  • MQT 4.60%
  • EPS Growth
  • HUMA N/A
  • MQT N/A
  • EPS
  • HUMA N/A
  • MQT N/A
  • Revenue
  • HUMA $818,000.00
  • MQT N/A
  • Revenue This Year
  • HUMA N/A
  • MQT N/A
  • Revenue Next Year
  • HUMA $949.92
  • MQT N/A
  • P/E Ratio
  • HUMA N/A
  • MQT N/A
  • Revenue Growth
  • HUMA N/A
  • MQT N/A
  • 52 Week Low
  • HUMA $1.15
  • MQT $8.59
  • 52 Week High
  • HUMA $6.77
  • MQT $10.67
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 36.87
  • MQT 55.46
  • Support Level
  • HUMA $1.43
  • MQT $9.47
  • Resistance Level
  • HUMA $1.67
  • MQT $9.56
  • Average True Range (ATR)
  • HUMA 0.15
  • MQT 0.07
  • MACD
  • HUMA -0.01
  • MQT 0.00
  • Stochastic Oscillator
  • HUMA 23.32
  • MQT 69.23

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About MQT Blackrock MuniYield Quality Fund II Inc.

BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, Housing, Corporate, and Tobacco.

Share on Social Networks: